Yongfen Qi
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 28, 2024
Intermedin Alleviates Diabetic Cardiomyopathy by Up-Regulating CPT-1β through Activation of the Phosphatidyl Inositol 3 Kinase/Protein Kinase B Signaling Pathway.Jie Zhao, Ling Han, Ya-Rong Zhang
|Oct 13, 2022
Endogenous Vasoactive Peptides and Vascular Aging-Related Diseases.Yao Chen, Yongfen Qi, Weiwei Lu
|Mar 28, 2022
The Protective Role of Hydrogen Sulfide and Its Impact on Gene Expression Profiling in Rat Model of COPD.Yanjing He, Yun Sun, Chengcheng Liao
|Feb 17, 2022
Intermedin1-53 Inhibits NLRP3 Inflammasome Activation by Targeting IRE1α in Cardiac Fibrosis.Lin-Shuang Zhang, Jin-Sheng Zhang, Yue-Long Hou
|May 02, 2021
Intermedin1-53 attenuates atherosclerotic plaque vulnerability by inhibiting CHOP-mediated apoptosis and inflammasome in macrophages.Jin-Ling Ren, Yao Chen, Lin-Shuang Zhang
|Nov 09, 2019
Intermedin1-53 Ameliorates Homocysteine-Promoted Atherosclerotic Calcification by Inhibiting Endoplasmic Reticulum Stress.Jin-Ling Ren, Yue-Long Hou, Xian-Qiang Ni
Pageof 1
